The identification of new molecular targets and biomarkers associated with high risk of
recurrence and response to therapy represents one of the main clinical challenges in the …

Endometrial cancer is the leading gynaecological malignancy in the western world and its
incidence is rising in tandem with the global epidemic of obesity. Early diagnosis is key to …

Uterine cancers are among the most prevalent gynecological malignancies, and
endometrial cancer (EC) is the most common in this group. This study used tissue-based …

Simple Summary Endometrial cancer (EC) is one of the main causes of cancer-related death
among women. Despite the advances in gynecologic oncology, the incidence of EC is on …

Simple Summary Endometrial cancer is the most common gynecologic malignancy arising
from the endometrium. Identification of serum biomarkers could be beneficial for its early …

The identification of new genes/proteins involved in breast cancer (BC) occurrence is widely
used to discover novel biomarkers and understand the molecular mechanisms of BC …

A specific form of endometrial cancer (EC) can develop in breast cancer patients previously
treated with tamoxifen (ET), an antagonist of estrogen receptor (ER) that inhibits proliferation …

C11orf54 is an ester hydrolase highly conserved across different species. C11orf54 has
been identified as a biomarker protein of renal cancers, but its exact function remains poorly …

Objective. The study is aimed at investigating the regulatory relationship between miR‐145‐
5p and ABRACL, and has tried at clarifying the mechanisms underlying the proliferation …

Regulation of cellular actin dynamics is pivotal in driving cell motility. During cancer
development, cells migrate to invade and spread; therefore, dysregulation of actin regulators …